Jennifer Lew
2021 - Annexon
In 2021, Jennifer Lew earned a total compensation of $3.1M as Executive Vice President and Chief Financial Officer at Annexon.
Compensation breakdown
| Non-Equity Incentive Plan | $164,440 |
|---|---|
| Option Awards | $2,558,750 |
| Salary | $404,567 |
| Total | $3,127,757 |
Lew received $2.6M in option awards, accounting for 82% of the total pay in 2021.
Lew also received $164.4K in non-equity incentive plan and $404.6K in salary.
Rankings
In 2021, Jennifer Lew's compensation ranked 4,270th out of 12,406 executives tracked by ExecPay. In other words, Lew earned more than 65.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,270 out of 12,406 | 66th |
Division Manufacturing | 1,757 out of 5,492 | 68th |
Major group Chemicals And Allied Products | 735 out of 2,368 | 69th |
Industry group Drugs | 656 out of 2,089 | 69th |
Industry Pharmaceutical Preparations | 464 out of 1,536 | 70th |
Source: SEC filing on April 25, 2023.
Lew's colleagues
We found five more compensation records of executives who worked with Jennifer Lew at Annexon in 2021.
2021
Douglas Love
Annexon
Chief Executive Officer
2021
Larry Mattheakis
Annexon
Chief Scientific Officer
2021
Ted Yednock
Annexon
EVP and Chief Innovation Officer
2021
Sanjay Keswani
Annexon
Chief Medical Officer
2021
Michael Overdorf
Annexon